Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_001754.4(RUNX1):c.*4238G>T

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA10652904

339793 (ClinVar)

Gene: RUNX1

Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: 5a1a3357-69e2-4980-bed5-5aa7c277d6fe

Approved on: 2020-05-13

Published on: 2020-06-02

HGVS expressions

NM_001754.4:c.*4238G>T

NM_001754.4(RUNX1):c.*4238G>T

NC_000021.9:g.34787897C>A

CM000683.2:g.34787897C>A

NC_000021.8:g.36160194C>A

CM000683.1:g.36160194C>A

NC_000021.7:g.35082064C>A

NG_011402.2:g.1201815G>T

NM_001001890.2:c.*4238G>T

NM_001001890.3:c.*4238G>T

ENST00000300305.7:c.*4238G>T

ENST00000344691.8:c.*4238G>T

ENST00000437180.5:c.*4238G>T

Benign

BP2 BA1

BS1 BS3 BS4 BP4 BP7 PS1 PS3 PS4 PP3 PP1 PM5 PM4 PM1 PM2 PM6 PVS1

Evidence Links 0

Expert Panel

Myeloid Malignancy VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Myeloid Malignancy VCEP

The c.*4238G>T variant in the 3' UTR has an MAF of 0.004815 (0.48%, 311/64584 alleles) in the non-Finish European subpopulation of the gnomAD v3 cohort and is ≥ 0.0015 (0.15%) (BA1). This variant is detected in a homozygous state in 1 individual in the gnomAD v2.1.1 population database (BP2). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP2.

BP2

1 homozygous individual reported in NFE population in gnomAD v2.1.1

BA1

The c.*4238G>T variant is reported at the highest MAF in the non-Finish European population in gnomAD v3, at a frequency of 0.004815 (311/64584 alleles), with 0 homozygotes. Note, the frequency of this variant in the Ashkenazi Jewish population is reported at 0.01835.

BS1

Variant meets BA1

BS3

N/A

BS4

N/A

BP4

N/A

BP7

N/A

PS1

N/A

PS3

N/A

PS4

Variant meets BA1

PP3

N/A

PP1

N/A

PM5

N/A

PM4

N/A

PM1

N/A

PM2

Variant meets BA1

PM6

N/A

PVS1

N/A

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.